BCRX

BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX)

About BioCryst Pharmaceuticals, Inc. - Common Stock (BCRX)

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Details

Daily high

$8.84

Daily low

$8.58

Price at open

$8.75

52 Week High

$11.22

52 Week Low

$6.00

Market cap

2.2B

Dividend yield

Volume

333,535

Avg. volume

4.6M

P/E ratio

-5.77

BioCryst Pharmaceuticals, Inc. - Common Stock News